(MTB) M&T Bank - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US55261F1049
Stock: Loans, Deposits, Mortgages, Cards, Wealth
Total Rating 54
Risk 87
Buy Signal 0.83
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 3.01% |
| Yield on Cost 5y | 4.70% |
| Yield CAGR 5y | 6.09% |
| Payout Consistency | 96.8% |
| Payout Ratio | 33.5% |
| Risk 5d forecast | |
|---|---|
| Volatility | 26.9% |
| Relative Tail Risk | -6.83% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.73 |
| Alpha | 5.71 |
| Character TTM | |
|---|---|
| Beta | 0.917 |
| Beta Downside | 1.128 |
| Drawdowns 3y | |
|---|---|
| Max DD | 30.46% |
| CAGR/Max DD | 0.58 |
Description: MTB M&T Bank December 17, 2025
M&T Bank Corporation (NYSE:MTB) is a U.S. bank holding company that operates Manufacturers and Traders Trust Company and Wilmington Trust, NA. It serves retail, commercial, and institutional clients through three segments: Commercial Bank, Retail Bank, and Institutional Services & Wealth Management.
Key product lines include commercial loans and leasing, letters of credit, cash-management services, and middle-market real-estate financing; consumer offerings span demand- and time-deposit accounts, auto and home-equity loans, credit cards, and residential mortgages; the Institutional Services arm provides trustee, agency, investment-management, brokerage, and family-office solutions.
Recent performance metrics (Q2 2024) show a loan portfolio of roughly $91 billion, deposits of $101 billion, a net interest margin of 3.6 %, an efficiency ratio of 58 %, and a return on equity of 12 %. The bank’s earnings are sensitive to the Federal Reserve’s rate policy and regional economic conditions, especially commercial-real-estate demand in the Midwest and Northeast.
For a deeper, data-driven valuation framework, you may find the ValueRay analysis worth reviewing.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: 2.85b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA 0.70 > 1.0 |
| NWC/Revenue: -958.7% < 20% (prev -946.1%; Δ -12.58% < -1%) |
| CFO/TA 0.02 > 3% & CFO 4.16b > Net Income 2.85b |
| Net Debt (-5.71b) to EBITDA (3.96b): -1.44 < 3 |
| Current Ratio: 0.32 > 1.5 & < 3 |
| Outstanding Shares: last quarter (156.6m) vs 12m ago -6.24% < -2% |
| Gross Margin: 74.62% > 18% (prev 0.64%; Δ 7398 % > 0.5%) |
| Asset Turnover: 5.84% > 50% (prev 6.44%; Δ -0.60% > 0%) |
| Interest Coverage Ratio: 0.77 > 6 (EBITDA TTM 3.96b / Interest Expense TTM 3.54b) |
Altman Z'' -3.08
| A: -0.55 (Total Current Assets 55.42b - Total Current Liabilities 173.42b) / Total Assets 213.51b |
| B: 0.10 (Retained Earnings 20.39b / Total Assets 213.51b) |
| C: 0.01 (EBIT TTM 2.72b / Avg Total Assets 210.81b) |
| D: 0.14 (Book Value of Equity 26.34b / Total Liabilities 184.33b) |
| Altman-Z'' Score: -3.08 = D |
What is the price of MTB shares?
As of February 10, 2026, the stock is trading at USD 236.25 with a total of 931,651 shares traded.
Over the past week, the price has changed by +4.75%, over one month by +11.61%, over three months by +26.50% and over the past year by +23.24%.
Over the past week, the price has changed by +4.75%, over one month by +11.61%, over three months by +26.50% and over the past year by +23.24%.
Is MTB a buy, sell or hold?
M&T Bank has received a consensus analysts rating of 3.90.
Therefore, it is recommended to buy MTB.
- StrongBuy: 9
- Buy: 3
- Hold: 8
- Sell: 0
- StrongSell: 1
What are the forecasts/targets for the MTB price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 230.9 | -2.3% |
| Analysts Target Price | 230.9 | -2.3% |
| ValueRay Target Price | 269.2 | 14% |
MTB Fundamental Data Overview February 09, 2026
P/E Trailing = 14.0088
P/E Forward = 12.7065
P/S = 4.0494
P/B = 1.3886
P/EG = 1.63
Revenue TTM = 12.31b USD
EBIT TTM = 2.72b USD
EBITDA TTM = 3.96b USD
Long Term Debt = 10.91b USD (from longTermDebt, last quarter)
Short Term Debt = 2.15b USD (from shortTermDebt, last quarter)
Debt = 13.06b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -5.71b USD (from netDebt column, last quarter)
Enterprise Value = -5.16b USD (37.19b + Debt 13.06b - CCE 55.42b)
Interest Coverage Ratio = 0.77 (Ebit TTM 2.72b / Interest Expense TTM 3.54b)
EV/FCF = -1.27x (Enterprise Value -5.16b / FCF TTM 4.07b)
FCF Yield = -78.83% (FCF TTM 4.07b / Enterprise Value -5.16b)
FCF Margin = 33.07% (FCF TTM 4.07b / Revenue TTM 12.31b)
Net Margin = 23.16% (Net Income TTM 2.85b / Revenue TTM 12.31b)
Gross Margin = 74.62% ((Revenue TTM 12.31b - Cost of Revenue TTM 3.12b) / Revenue TTM)
Gross Margin QoQ = 70.51% (prev none%)
Tobins Q-Ratio = -0.02 (set to none) (Enterprise Value -5.16b / Total Assets 213.51b)
Interest Expense / Debt = 6.57% (Interest Expense 858.0m / Debt 13.06b)
Taxrate = 21.83% (212.0m / 971.0m)
NOPAT = 2.13b (EBIT 2.72b * (1 - 21.83%))
Current Ratio = 0.32 (Total Current Assets 55.42b / Total Current Liabilities 173.42b)
Debt / Equity = 0.45 (Debt 13.06b / totalStockholderEquity, last quarter 29.18b)
Debt / EBITDA = -1.44 (Net Debt -5.71b / EBITDA 3.96b)
Debt / FCF = -1.40 (Net Debt -5.71b / FCF TTM 4.07b)
Total Stockholder Equity = 28.86b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.35% (Net Income 2.85b / Total Assets 213.51b)
RoE = 9.88% (Net Income TTM 2.85b / Total Stockholder Equity 28.86b)
RoCE = 6.84% (EBIT 2.72b / Capital Employed (Equity 28.86b + L.T.Debt 10.91b))
RoIC = 5.30% (NOPAT 2.13b / Invested Capital 40.12b)
WACC = 8.21% (E(37.19b)/V(50.25b) * Re(9.29%) + D(13.06b)/V(50.25b) * Rd(6.57%) * (1-Tc(0.22)))
Discount Rate = 9.29% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -3.10%
[DCF Debug] Terminal Value 77.09% ; FCFF base≈3.45b ; Y1≈3.39b ; Y5≈3.48b
Fair Price DCF = 421.1 (EV 59.01b - Net Debt -5.71b = Equity 64.72b / Shares 153.7m; r=8.21% [WACC]; 5y FCF grow -2.43% → 2.90% )
EPS Correlation: 43.15 | EPS CAGR: 16.66% | SUE: 0.71 | # QB: 0
Revenue Correlation: 63.37 | Revenue CAGR: 24.41% | SUE: 1.95 | # QB: 1
EPS next Quarter (2026-03-31): EPS=4.03 | Chg30d=-0.016 | Revisions Net=+3 | Analysts=15
EPS current Year (2026-12-31): EPS=18.76 | Chg30d=+0.078 | Revisions Net=+4 | Growth EPS=+10.4% | Growth Revenue=+2.9%
EPS next Year (2027-12-31): EPS=20.97 | Chg30d=+0.178 | Revisions Net=+4 | Growth EPS=+11.8% | Growth Revenue=+3.6%
P/E Forward = 12.7065
P/S = 4.0494
P/B = 1.3886
P/EG = 1.63
Revenue TTM = 12.31b USD
EBIT TTM = 2.72b USD
EBITDA TTM = 3.96b USD
Long Term Debt = 10.91b USD (from longTermDebt, last quarter)
Short Term Debt = 2.15b USD (from shortTermDebt, last quarter)
Debt = 13.06b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -5.71b USD (from netDebt column, last quarter)
Enterprise Value = -5.16b USD (37.19b + Debt 13.06b - CCE 55.42b)
Interest Coverage Ratio = 0.77 (Ebit TTM 2.72b / Interest Expense TTM 3.54b)
EV/FCF = -1.27x (Enterprise Value -5.16b / FCF TTM 4.07b)
FCF Yield = -78.83% (FCF TTM 4.07b / Enterprise Value -5.16b)
FCF Margin = 33.07% (FCF TTM 4.07b / Revenue TTM 12.31b)
Net Margin = 23.16% (Net Income TTM 2.85b / Revenue TTM 12.31b)
Gross Margin = 74.62% ((Revenue TTM 12.31b - Cost of Revenue TTM 3.12b) / Revenue TTM)
Gross Margin QoQ = 70.51% (prev none%)
Tobins Q-Ratio = -0.02 (set to none) (Enterprise Value -5.16b / Total Assets 213.51b)
Interest Expense / Debt = 6.57% (Interest Expense 858.0m / Debt 13.06b)
Taxrate = 21.83% (212.0m / 971.0m)
NOPAT = 2.13b (EBIT 2.72b * (1 - 21.83%))
Current Ratio = 0.32 (Total Current Assets 55.42b / Total Current Liabilities 173.42b)
Debt / Equity = 0.45 (Debt 13.06b / totalStockholderEquity, last quarter 29.18b)
Debt / EBITDA = -1.44 (Net Debt -5.71b / EBITDA 3.96b)
Debt / FCF = -1.40 (Net Debt -5.71b / FCF TTM 4.07b)
Total Stockholder Equity = 28.86b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.35% (Net Income 2.85b / Total Assets 213.51b)
RoE = 9.88% (Net Income TTM 2.85b / Total Stockholder Equity 28.86b)
RoCE = 6.84% (EBIT 2.72b / Capital Employed (Equity 28.86b + L.T.Debt 10.91b))
RoIC = 5.30% (NOPAT 2.13b / Invested Capital 40.12b)
WACC = 8.21% (E(37.19b)/V(50.25b) * Re(9.29%) + D(13.06b)/V(50.25b) * Rd(6.57%) * (1-Tc(0.22)))
Discount Rate = 9.29% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -3.10%
[DCF Debug] Terminal Value 77.09% ; FCFF base≈3.45b ; Y1≈3.39b ; Y5≈3.48b
Fair Price DCF = 421.1 (EV 59.01b - Net Debt -5.71b = Equity 64.72b / Shares 153.7m; r=8.21% [WACC]; 5y FCF grow -2.43% → 2.90% )
EPS Correlation: 43.15 | EPS CAGR: 16.66% | SUE: 0.71 | # QB: 0
Revenue Correlation: 63.37 | Revenue CAGR: 24.41% | SUE: 1.95 | # QB: 1
EPS next Quarter (2026-03-31): EPS=4.03 | Chg30d=-0.016 | Revisions Net=+3 | Analysts=15
EPS current Year (2026-12-31): EPS=18.76 | Chg30d=+0.078 | Revisions Net=+4 | Growth EPS=+10.4% | Growth Revenue=+2.9%
EPS next Year (2027-12-31): EPS=20.97 | Chg30d=+0.178 | Revisions Net=+4 | Growth EPS=+11.8% | Growth Revenue=+3.6%